Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of 8.16% is 25% below its 5-year average of 10.93%, near the low end of its 5-year range (1.42%–84.38%).
1.23% above its 12-month average of 8.06%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-07-05): 7.10%.
NET PROFIT MARGIN
8.16%
NET PROFIT MARGIN AVG TTM
8.06%
NET PROFIT MARGIN AVG 3Y
8.74%
NET PROFIT MARGIN AVG 5Y
10.93%
NET PROFIT MARGIN AVG 10Y
11.62%
NET PROFIT MARGIN AVG 15Y
9.46%
NET PROFIT MARGIN AVG 20Y
8.62%
CURRENT VS TTM AVG
+1.23%
CURRENT VS 3Y AVG
-6.67%
CURRENT VS 5Y AVG
-25.34%
CURRENT VS 10Y AVG
-29.80%
CURRENT VS 15Y AVG
-13.77%
CURRENT VS 20Y AVG
-5.32%
SECTOR MEDIAN · HEALTHCARE
9.21%
median of 90 covered companies
CURRENT VS SECTOR MEDIAN
-11.35%
vs the sector median at left
Market Cap
$15.46B
Net Profit Margin
17.26%
TTM Avg
12.25%
3Y Avg
14.36%
5Y Avg
15.15%
Market Cap
$17.06B
Net Profit Margin
17.67%
TTM Avg
18.50%
3Y Avg
17.20%
5Y Avg
16.74%
Market Cap
$14.62B
Net Profit Margin
35.33%
TTM Avg
28.88%
3Y Avg
23.04%
5Y Avg
19.31%
Market Cap
$13.59B
Net Profit Margin
-17.77%
TTM Avg
-60.53%
3Y Avg
-62.93%
5Y Avg
-77.31%
Market Cap
$18.51B
Net Profit Margin
9.48%
TTM Avg
10.17%
3Y Avg
9.38%
5Y Avg
6.86%
Market Cap
$13.33B
Net Profit Margin
-5.96%
TTM Avg
-1.67%
3Y Avg
5.09%
5Y Avg
7.31%
Market Cap
$19.81B
Net Profit Margin
-2.79%
TTM Avg
-14.44%
3Y Avg
-3.94%
5Y Avg
-4.74%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Revvity, Inc. (RVTY) | $15.99B | 8.16% | 8.06% | 8.74% | 10.93% |
| Solventum Corporation (SOLV)vs › | $15.46B | 17.26% | 12.25% | 14.36% | 15.15% |
| Medpace Holdings, Inc. (MEDP)vs › | $17.06B | 17.67% | 18.50% | 17.20% | 16.74% |
| Exelixis, Inc. (EXEL)vs › | $14.62B | 35.33% | 28.88% | 23.04% | 19.31% |
| Tempus AI, Inc. (TEM)vs › | $13.59B | -17.77% | -60.53% | -62.93% | -77.31% |
| Zimmer Biomet Holdings, Inc. (ZBH)vs › | $18.51B | 9.48% | 10.17% | 9.38% | 6.86% |
| Charles River Laboratories International, Inc. (CRL)vs › | $13.33B | -5.96% | -1.67% | 5.09% | 7.31% |
| Penumbra, Inc. (PEN)vs › | $12.52B | 10.67% | 6.92% | 5.54% | 3.35% |
| Viatris Inc. (VTRS)vs › | $19.81B | -2.79% | -14.44% | -3.94% | -4.74% |
| Encompass Health Corporation (EHC)vs › | $12.11B | 10.01% | 9.01% | 7.89% | 8.30% |
Operating Margin
12.3%
Net Profit Margin
8.2%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-07-05 | 7.10% |
| 2026-04-05 | 5.73% |
| 2025-12-28 | 12.74% |
| 2025-09-28 | 6.67% |
| 2025-06-29 | 7.67% |
| 2025-03-30 | 6.35% |
| 2024-12-29 | 13.03% |
| 2024-09-29 | 13.74% |
| 2024-06-30 | 11.44% |
| 2024-03-31 | 4.27% |
| 2023-12-31 | 14.76% |
| 2023-09-30 | 1.42% |
| 2023-06-30 | 5.01% |
| 2023-04-02 | 84.38% |
| 2023-01-01 | 18.57% |
| 2022-10-02 | 9.77% |
| 2022-06-30 | 20.01% |
| 2022-03-31 | 18.37% |
| 2021-12-31 | 18.50% |
| 2021-09-30 | 12.50% |
| 2021-06-30 | 20.02% |
| 2021-03-31 | 29.01% |
| 2020-12-31 | 28.08% |
| 2020-09-30 | 18.33% |
| 2020-06-30 | 16.90% |
| 2020-03-31 | 5.17% |
| 2019-12-31 | 8.01% |
| 2019-09-30 | 8.28% |
| 2019-06-30 | 9.56% |
| 2019-03-31 | 5.46% |
| 2018-12-31 | 9.43% |
| 2018-09-30 | 11.40% |
| 2018-06-30 | 9.19% |
| 2018-03-31 | 4.04% |
| 2017-12-31 | -12.90% |
| 2017-09-30 | 17.44% |
| 2017-06-30 | 4.33% |
| 2017-03-31 | 7.51% |
| 2016-12-31 | 11.44% |
| 2016-09-30 | 10.49% |
| 2016-06-30 | 11.15% |
| 2016-03-31 | 8.81% |
| 2015-12-31 | 11.22% |
| 2015-09-30 | 9.74% |
| 2015-06-30 | 8.68% |
| 2015-03-31 | 7.65% |
| 2014-12-31 | 5.06% |
| 2014-09-30 | 7.80% |
| 2014-06-30 | 9.08% |
| 2014-03-31 | 6.43% |
| 2013-12-31 | 11.27% |
| 2013-09-30 | 7.67% |
| 2013-06-30 | 5.14% |
| 2013-03-31 | 6.37% |
| 2012-12-31 | -2.83% |
| 2012-09-30 | 5.81% |
| 2012-06-30 | 6.45% |
| 2012-03-31 | 4.42% |
| 2011-12-31 | -14.68% |
| 2011-09-30 | 5.88% |
| 2011-06-30 | 6.21% |
| 2011-03-31 | 5.56% |
| 2010-12-31 | 9.06% |
| 2010-09-30 | 6.33% |
| 2010-06-30 | 11.58% |
| 2010-03-31 | 5.24% |
| 2009-12-31 | 7.85% |
| 2009-09-30 | 3.11% |
| 2009-06-30 | 4.95% |
| 2009-03-31 | 3.49% |
| 2008-12-31 | 7.28% |
| 2008-09-30 | 10.28% |
| 2008-06-30 | 6.01% |
| 2008-03-31 | 4.18% |
| 2007-12-31 | 10.28% |
| 2007-09-30 | 7.06% |
| 2007-06-30 | 7.70% |
| 2007-03-31 | 3.65% |
| 2006-12-31 | 9.77% |
| 2006-09-30 | 7.69% |
| 2006-06-30 | 6.49% |
| 2006-03-31 | 6.64% |
| 2005-12-31 | -1.37% |
| 2005-09-30 | 8.80% |
| 2005-06-30 | 6.79% |
| 2005-03-31 | 4.76% |
| 2004-12-31 | 7.92% |
| 2004-09-30 | 5.95% |
| 2004-06-30 | 5.05% |
| 2004-03-31 | 3.37% |
| 2003-12-31 | 6.46% |
| 2003-09-30 | 3.89% |
| 2003-06-30 | 2.23% |
| 2003-03-31 | 0.93% |
| 2002-12-31 | 0.17% |
| 2002-09-30 | 2.66% |
